|
|
|
|
| LEADER |
01357nam a2200265 u 4500 |
| 001 |
EB001839682 |
| 003 |
EBX01000000000000001003671 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 245 |
0 |
0 |
|a Long-term use of acamprosate calcium for alcoholism
|h Elektronische Ressource
|b a review of the clinical effectiveness, safety, and guidelines
|
| 260 |
|
|
|a [Ottawa]
|b Canadian Agency for Drugs and Technologies in Health
|c 2015, 29 May 2015
|
| 300 |
|
|
|a 1 PDF file (15 pages)
|b illustrations
|
| 653 |
|
|
|a Alcoholism / drug therapy
|
| 653 |
|
|
|a Alcohol Deterrents
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Practice Guidelines as Topic
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Rapid response report: summary with critical appraisal
|
| 500 |
|
|
|a Title from PDF caption
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK304665
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to review the available evidence on the clinical effectiveness and safety for long term (> 1 year) use of acamprosate to treat adults with alcoholism and to review evidence-based guidelines on the use of acamprosate for treating alcoholism
|